3d Bioprinting Market

3d Bioprinting Market

3D Bioprinting Market Forecasts to 2028 - Global Analysis By Component (3D Bioprinters and Bioinks), Material (Biomaterials), Application (Medical, Drug Testing & Research, Clinical Transplantation, Food Testing and Other Applications), End User and By Geography

4.1 (60 reviews)
4.1 (60 reviews)
Published: 2023 ID: SMRC22904

This report covers the impact of COVID-19 on this global market

Years Covered


Estimated Year Value (2022)

US $2.05 BN

Projected Year Value (2028)

US $5.50 BN

CAGR (2022 - 2028)


Regions Covered

North America, Europe, Asia Pacific, South America, and Middle East & Africa

Countries Covered

US, Canada, Mexico, Germany, UK, Italy, France, Spain, Japan, China, India, Australia, New Zealand, South Korea, Rest of Asia Pacific, South America, Argentina, Brazil, Chile, Middle East & Africa, Saudi Arabia, UAE, Qatar, and South Africa

Largest Market

North America

Highest Growing Market

Asia Pacific

According to Stratistics MRC, the Global 3D Bioprinting Market is accounted for $2.05 billion in 2022 and is expected to reach $5.50 billion by 2028 growing at a CAGR of 17.9% during the forecast period. Live cells are combined with biomaterials in a process called 3D bioprinting that enables precise layer-by-layer deposition of the cells or bio-ink. This is distinguished by hierarchical structural characteristics that preserve cellular viability in 3D environments to produce multifaceted and complex tissues. The end results of this technique can be products that mimic the biological and functional characteristics of the tissues and structures that make up the human body naturally.

According to an article by Interesting Engineering, engineers at the University of New South Wales, Sydney, published a paper wherein they successfully developed a 3D bio-printed device, F3DB, that can directly transfer multi-layered biomaterials on the surface of the tissues and internal organs.

Market Dynamics:


Increasing use of 3D bioprinting in the pharmaceutical and cosmetic industries

The market has been significantly influenced by the growing use of 3D bioprinting in the pharmaceutical and cosmetic industries. Complex 3D structures can be created using 3D bioprinting, which is not possible with conventional techniques. This has made it possible to produce intricate drug formulations and molecules, as well as cosmetic products like synthetic skin, hair follicles, and other tissues. The pharmaceutical and cosmetic industries' rising need for 3D bioprinted products has been a key market driver.


Lack of qualified professionals

One of the main market constraints is the lack of qualified professionals in the market. The market's expansion has been hampered by a lack of qualified professionals as demand for cutting-edge 3D bioprinting technology rises. To operate and maintain 3D bioprinting equipment, skilled professionals are required. The likelihood that 3D bioprinting technology will realize its full potential has been reduced by a lack of qualified professionals. The high cost of hiring and training qualified professionals is another factor impeding market expansion.


Funding from the governments

Governments from various nations are working together to fund research and development projects involving 3D bioprinting. For instance, the first five research universities received a grant from the US Food and Drug Administration (FDA) for three dimensional bioprinting research and development totaling USD 2.5 billion. The grant recipients included Harvard University, Carnegie Mellon University, Rutgers University, Massachusetts Institute of Technology, and Georgia Institute of Technology. This is a significant factor that is predicted to boost the three-dimensional bioprinting market's revenue growth over the forecast period.


Absence of regulatory standards

The absence of regulatory standards for 3D bioprinting is anticipated to impede market revenue growth. For instance, the FDA's Center for Biologics Evaluation and Research (CBER), which oversees the sale of biological commodities, has neither approved any 3D-printed biological products nor made any explicit recommendations regarding their use. The absence of regulatory standards, however, places a constraint on the growth of the 3D bioprinting market.

Covid-19 Impact

Due to disrupted supply chains, increased demand for treatments and materials, and manufacturing technology advancements, the COVID-19 pandemic significantly accelerated these fields' technological development. There is a growing need for organ and tissue production as the number of COVID-19 illness cases rises. The COVID-19 vaccine is being developed by a number of 3D bioprinting market participants to mitigate the effects of the outbreak. As well as the number of industry participants, the demand for pharmaceutical products is rising. Moreover, the 3D printing community responded to the COVID-19 situation by supporting the development of essential hospital equipment.

The 3D bioprinters segment is expected to be the largest during the forecast period

Due to the widespread use of pharmaceutical pills to treat a variety of chronic conditions, the 3D bioprinters segment is expected to hold the largest market share during the forecast period. The growing demand for pharmaceuticals and the effective application of bio-drugs in this technology are other factors driving the segment. Along with an increase in industry participants, the demand for pharmaceutical products is also rising. Millions of people regularly take pills and capsules for medical reasons all over the world. As a result, it is anticipated that this market segment will expand profitably over the course of the forecast period.

The medical segment is expected to have the highest CAGR during the forecast period

The medical segment is expected to witness lucrative growth during the forecast period. The market for 3D bioprinting is expanding due to the widespread use of pharmaceutical pills to treat a variety of chronic diseases. Additionally, the segment is also being driven by the expanding demand for medicines and the efficient use of bio-drugs in this technology.

Region with largest share:

Over the forecast period, North America is anticipated to dominate the global market. The increased target population count in North America is blamed for the area's dominance. The North American 3D bioprinting market is expected to experience growth opportunities due to the presence of key players and the region's sophisticated healthcare infrastructure. In the upcoming years, it is anticipated that increased regional players' investments in a variety of R&D initiatives will also help the market grow.

Region with highest CAGR:

Asia Pacific is estimated to witness the highest CAGR over the projection timeframe, owing to a senior population and favorable government initiatives and policies to strengthen the healthcare sector in this region. By 2030, the Japanese government projects that the regenerative medicine industry will have grown to 1 trillion yen. Due to the rise in COVID-19 cases and government R&D spending, Japan and China accounted for the lion's share of the revenue. Furthermore, COVID-19's increased mortality rate and the scarcity of organ donors are expected to fuel the expansion of the regional market.

Key players in the market

Some of the key players profiled in the 3D Bioprinting Market include 3D Bioprinting Solutions, 3D Systems Corporation, Advanced Solutions Life Sciences, LLC, Allevi Inc., Arcam AB, Aspect Biosystems Ltd., Bico group ab, Bio3D Technologies Pte. Ltd., Cellink, Collplant Biotechnologies Ltd., Cyfuse Biomedical K.K., Electro Optical Systems, Envision TEC GmbH, Foldink Life Science Technologies, Formlabs, Inc., GE Healthcare, GeSIM GmbH, Inventia Life Science PTY LTD, Optomec Inc., Organovo Holdings Inc., Pandorum Technologies pvt. ltd., Poietis, Precise Bio, REGEMAT 3D, Regenovo Biotechnology Co. Ltd., Renishaw plc., Revotek co., ltd., Rokit Healthcare, inc. and Stratasys Ltd.

Key Developments:

In June 2022, Humabiologics and REGEMAT 3D announced a non-exclusive distribution agreement in order to respond to the increasing demand and serve a broader life science customer base of academic institutes and its industry partners in the European drug testing and bioprinting market.

In May 2022, Organovo Holdings announced it had successfully advanced its first Inflammatory Bowel Disease (IBD) model to target the discovery and validation of Crohn’s Disease. Based on the internal data, the company believes its IBD model can correctly demonstrate important aspects of Crohn’s patient biology that differ from a non-diseased person.

In April 2021, Aspect Biosystems Ltd announced a partnership with JDRF, a pioneer in diabetes research and advocacy. Through the partnership, the companies will focus on developing 3D bio-printed tissue that is capable of treating type 1 diabetes.

Components Covered:
• 3D Bioprinters
• Bioinks

Materials Covered:
• Biomaterials

Applications Covered:
• Medical
• Drug Testing & Research
• Clinical Transplantation
• Food Testing
• Regenerative Medicine
• Consumer/Personal Product Testing
• Cancer Research
• Biosensors
• Other Applications

End Users Covered:
• Research Organizations & Academic Institutes
• Biopharmaceutical Companies
• Hospitals

Regions Covered:
• North America
o US
o Canada
o Mexico
• Europe
o Germany
o UK
o Italy
o France
o Spain
o Rest of Europe
• Asia Pacific
o Japan
o China
o India
o Australia
o New Zealand
o South Korea
o Rest of Asia Pacific
• South America
o Argentina
o Brazil
o Chile
o Rest of South America
• Middle East & Africa
o Saudi Arabia
o Qatar
o South Africa
o Rest of Middle East & Africa

What our report offers:
- Market share assessments for the regional and country-level segments
- Strategic recommendations for the new entrants
- Covers Market data for the years 2020, 2021, 2022, 2025, and 2028
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements

Free Customization Offerings:
All the customers of this report will be entitled to receive one of the following free customization options:
• Company Profiling
o Comprehensive profiling of additional market players (up to 3)
o SWOT Analysis of key players (up to 3)
• Regional Segmentation
o Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
o Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface
2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
2.4.1 Data Mining
2.4.2 Data Analysis
2.4.3 Data Validation
2.4.4 Research Approach
2.5 Research Sources
2.5.1 Primary Research Sources
2.5.2 Secondary Research Sources
2.5.3 Assumptions

3 Market Trend Analysis
3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 Application Analysis
3.7 End User Analysis
3.8 Emerging Markets
3.9 Impact of Covid-19

4 Porters Five Force Analysis
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry

5 Global 3D Bioprinting Market, By Component
5.1 Introduction
5.2 3D Bioprinters
5.2.1 Microextrusion Bioprinting
5.2.2 Inkjet 3D Bioprinting
5.2.3 Syringe/extrusion Bioprinting
5.2.4 Laser-Assisted Bioprinting
5.2.5 Stereolithography-Based Bioprinting
5.2.6 Magnetic 3D bioprinting
5.2.7 Other 3D Bioprinters
5.3 Bioinks
5.3.1 Natural
5.3.2 Hybrid
5.3.3 Synthetic

6 Global 3D Bioprinting Market, By Material
6.1 Introduction
6.2 Biomaterials
6.2.1 Living Cells
6.2.2 Hydrogels
6.2.3 Extracellular Matrices
6.2.4 Other Biomaterials

7 Global 3D Bioprinting Market, By Application
7.1 Introduction
7.2 Medical
7.2.1 Tissue And Organ Generation
7.2.2 Medical Pills
7.2.3 Prosthetics And Implants
7.2.4 Other Medicals
7.3 Drug Testing & Research
7.4 Clinical Transplantation
7.5 Food Testing
7.6 Regenerative Medicine
7.7 Consumer/Personal Product Testing
7.8 Cancer Research
7.9 Biosensors
7.10 Other Applications

8 Global 3D Bioprinting Market, By End User
8.1 Introduction
8.2 Research Organizations & Academic Institutes
8.3 Biopharmaceutical Companies
8.4 Hospitals

9 Global 3D Bioprinting Market, By Geography
9.1 Introduction
9.2 North America
9.2.1 US
9.2.2 Canada
9.2.3 Mexico
9.3 Europe
9.3.1 Germany
9.3.2 UK
9.3.3 Italy
9.3.4 France
9.3.5 Spain
9.3.6 Rest of Europe
9.4 Asia Pacific
9.4.1 Japan
9.4.2 China
9.4.3 India
9.4.4 Australia
9.4.5 New Zealand
9.4.6 South Korea
9.4.7 Rest of Asia Pacific
9.5 South America
9.5.1 Argentina
9.5.2 Brazil
9.5.3 Chile
9.5.4 Rest of South America
9.6 Middle East & Africa
9.6.1 Saudi Arabia
9.6.2 UAE
9.6.3 Qatar
9.6.4 South Africa
9.6.5 Rest of Middle East & Africa

10 Key Developments
10.1 Agreements, Partnerships, Collaborations and Joint Ventures
10.2 Acquisitions & Mergers
10.3 New Product Launch
10.4 Expansions
10.5 Other Key Strategies

11 Company Profiling
11.1 3D Bioprinting Solutions
11.2 3D Systems Corporation
11.3 Advanced Solutions Life Sciences, LLC
11.4 Allevi Inc.
11.5 Arcam AB
11.6 Aspect Biosystems Ltd.
11.7 Bico group ab
11.8 Bio3D Technologies Pte. Ltd.
11.9 Cellink
11.10 Collplant Biotechnologies Ltd.
11.11 Cyfuse Biomedical K.K.
11.12 Electro Optical Systems
11.13 Envision TEC GmbH
11.14 Foldink Life Science Technologies
11.15 Formlabs, Inc.
11.16 GE Healthcare
11.17 GeSIM GmbH
11.18 Inventia Life Science PTY LTD
11.19 Optomec Inc.
11.20 Organovo Holdings Inc.
11.21 Pandorum Technologies pvt. ltd.
11.22 Poietis
11.23 Precise Bio
11.24 REGEMAT 3D
11.25 Regenovo Biotechnology Co. Ltd.
11.26 Renishaw plc.
11.27 Revotek co., ltd.
11.28 Rokit Healthcare, inc.
11.29 Stratasys Ltd

List of Tables
1 Global 3D Bioprinting Market Outlook, By Region (2020-2028) ($MN)
2 Global 3D Bioprinting Market Outlook, By Component (2020-2028) ($MN)
3 Global 3D Bioprinting Market Outlook, By 3D Bioprinters (2020-2028) ($MN)
4 Global 3D Bioprinting Market Outlook, By Microextrusion Bioprinting (2020-2028) ($MN)
5 Global 3D Bioprinting Market Outlook, By Inkjet 3D Bioprinting (2020-2028) ($MN)
6 Global 3D Bioprinting Market Outlook, By Syringe/extrusion Bioprinting (2020-2028) ($MN)
7 Global 3D Bioprinting Market Outlook, By Laser-Assisted Bioprinting (2020-2028) ($MN)
8 Global 3D Bioprinting Market Outlook, By Stereolithography-Based Bioprinting (2020-2028) ($MN)
9 Global 3D Bioprinting Market Outlook, By Magnetic 3D bioprinting (2020-2028) ($MN)
10 Global 3D Bioprinting Market Outlook, By Other 3D Bioprinters (2020-2028) ($MN)
11 Global 3D Bioprinting Market Outlook, By Bioinks (2020-2028) ($MN)
12 Global 3D Bioprinting Market Outlook, By Natural (2020-2028) ($MN)
13 Global 3D Bioprinting Market Outlook, By Hybrid (2020-2028) ($MN)
14 Global 3D Bioprinting Market Outlook, By Synthetic (2020-2028) ($MN)
15 Global 3D Bioprinting Market Outlook, By Material (2020-2028) ($MN)
16 Global 3D Bioprinting Market Outlook, By Biomaterials (2020-2028) ($MN)
17 Global 3D Bioprinting Market Outlook, By Living Cells (2020-2028) ($MN)
18 Global 3D Bioprinting Market Outlook, By Hydrogels (2020-2028) ($MN)
19 Global 3D Bioprinting Market Outlook, By Extracellular Matrices (2020-2028) ($MN)
20 Global 3D Bioprinting Market Outlook, By Other Biomaterials (2020-2028) ($MN)
21 Global 3D Bioprinting Market Outlook, By Application (2020-2028) ($MN)
22 Global 3D Bioprinting Market Outlook, By Medical (2020-2028) ($MN)
23 Global 3D Bioprinting Market Outlook, By Tissue And Organ Generation (2020-2028) ($MN)
24 Global 3D Bioprinting Market Outlook, By Medical Pills (2020-2028) ($MN)
25 Global 3D Bioprinting Market Outlook, By Prosthetics And Implants (2020-2028) ($MN)
26 Global 3D Bioprinting Market Outlook, By Other Medicals (2020-2028) ($MN)
27 Global 3D Bioprinting Market Outlook, By Drug Testing & Research (2020-2028) ($MN)
28 Global 3D Bioprinting Market Outlook, By Clinical Transplantation (2020-2028) ($MN)
29 Global 3D Bioprinting Market Outlook, By Food Testing (2020-2028) ($MN)
30 Global 3D Bioprinting Market Outlook, By Regenerative Medicine (2020-2028) ($MN)
31 Global 3D Bioprinting Market Outlook, By Consumer/Personal Product Testing (2020-2028) ($MN)
32 Global 3D Bioprinting Market Outlook, By Cancer Research (2020-2028) ($MN)
33 Global 3D Bioprinting Market Outlook, By Biosensors (2020-2028) ($MN)
34 Global 3D Bioprinting Market Outlook, By Other Applications (2020-2028) ($MN)
35 Global 3D Bioprinting Market Outlook, By End User (2020-2028) ($MN)
36 Global 3D Bioprinting Market Outlook, By Research Organizations & Academic Institutes (2020-2028) ($MN)
37 Global 3D Bioprinting Market Outlook, By Biopharmaceutical Companies (2020-2028) ($MN)
38 Global 3D Bioprinting Market Outlook, By Hospitals (2020-2028) ($MN)

Note: Tables for North America, Europe, Asia Pacific, South America and Middle East & Africa Regions are also represented in the same manner as above.

List of Figures


Research Methodology

We at Stratistics opt for an extensive research approach which involves data mining, data validation, and data analysis. The various research sources include in-house repository, secondary research, competitor’s sources, social media research, client internal data, and primary research.

Our team of analysts prefers the most reliable and authenticated data sources in order to perform the comprehensive literature search. With access to most of the authenticated data bases our team highly considers the best mix of information through various sources to obtain extensive and accurate analysis.

Each report takes an average time of a month and a team of 4 industry analysts. The time may vary depending on the scope and data availability of the desired market report. The various parameters used in the market assessment are standardized in order to enhance the data accuracy.

Data Mining

The data is collected from several authenticated, reliable, paid and unpaid sources and is filtered depending on the scope & objective of the research. Our reports repository acts as an added advantage in this procedure. Data gathering from the raw material suppliers, distributors and the manufacturers is performed on a regular basis, this helps in the comprehensive understanding of the products value chain. Apart from the above mentioned sources the data is also collected from the industry consultants to ensure the objective of the study is in the right direction.

Market trends such as technological advancements, regulatory affairs, market dynamics (Drivers, Restraints, Opportunities and Challenges) are obtained from scientific journals, market related national & international associations and organizations.

Data Analysis

From the data that is collected depending on the scope & objective of the research the data is subjected for the analysis. The critical steps that we follow for the data analysis include:

  • Product Lifecycle Analysis
  • Competitor analysis
  • Risk analysis
  • Porters Analysis
  • PESTEL Analysis
  • SWOT Analysis

The data engineering is performed by the core industry experts considering both the Marketing Mix Modeling and the Demand Forecasting. The marketing mix modeling makes use of multiple-regression techniques to predict the optimal mix of marketing variables. Regression factor is based on a number of variables and how they relate to an outcome such as sales or profits.

Data Validation

The data validation is performed by the exhaustive primary research from the expert interviews. This includes telephonic interviews, focus groups, face to face interviews, and questionnaires to validate our research from all aspects. The industry experts we approach come from the leading firms, involved in the supply chain ranging from the suppliers, distributors to the manufacturers and consumers so as to ensure an unbiased analysis.

We are in touch with more than 15,000 industry experts with the right mix of consultants, CEO's, presidents, vice presidents, managers, experts from both supply side and demand side, executives and so on.

The data validation involves the primary research from the industry experts belonging to:

  • Leading Companies
  • Suppliers & Distributors
  • Manufacturers
  • Consumers
  • Industry/Strategic Consultants

Apart from the data validation the primary research also helps in performing the fill gap research, i.e. providing solutions for the unmet needs of the research which helps in enhancing the reports quality.

For more details about research methodology, kindly write to us at info@strategymrc.com

Frequently Asked Questions

In case of any queries regarding this report, you can contact the customer service by filing the “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929

Yes, the samples are available for all the published reports. You can request them by filling the “Request Sample” option available in this page.

Yes, you can request a sample with your specific requirements. All the customized samples will be provided as per the requirement with the real data masked.

All our reports are available in Digital PDF format. In case if you require them in any other formats, such as PPT, Excel etc you can submit a request through “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929

We offer a free 15% customization with every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at info@strategymrc.com or call us on +1-301-202-5929.

We have 3 different licensing options available in electronic format.

  • Single User Licence: Allows one person, typically the buyer, to have access to the ordered product. The ordered product cannot be distributed to anyone else.
  • 2-5 User Licence: Allows the ordered product to be shared among a maximum of 5 people within your organisation.
  • Corporate License: Allows the product to be shared among all employees of your organisation regardless of their geographical location.

All our reports are typically be emailed to you as an attachment.

To order any available report you need to register on our website. The payment can be made either through CCAvenue or PayPal payments gateways which accept all international cards.

We extend our support to 6 months post sale. A post sale customization is also provided to cover your unmet needs in the report.

Request Customization

We provide a free 15% customization on every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at info@strategymrc.com or call us on +1-301-202-5929.

Note: This customization is absolutely free until it falls under the 15% bracket. If your requirement exceeds this a feasibility check will be performed. Post that, a quote will be provided along with the timelines.


Assured Quality

Assured Quality

Best in class reports with high standard of research integrity

24X7 Research Support

24X7 Research Support

Continuous support to ensure the best customer experience.

Free Customization

Free Customization

Adding more values to your product of interest.

Safe and Secure Access

Safe & Secure Access

Providing a secured environment for all online transactions.

Trusted by 600+ Brands

Trusted by 600+ Brands

Serving the most reputed brands across the world.